Tag: Biotechnology

Impact Newswire brings you the latest in Biotechnology news.

Gilead Sciences
Global, United States

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

— Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 — — Seladelpar Phase 3 Data Demonstrates a Best-in-Disease Profile for Second-Line PBC — — Acquisition Expands Gilead’s Long-Standing Commitment to Patients with Liver Diseases — February 12, 2024 08:30 AM Eastern Standard Time FOSTER … Continue reading Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Impact Newswire
Veracyte
Global, United States

Veracyte Completes Acquisition of C2i Genomics

Extends Veracyte’s novel diagnostics platform with whole-genome minimal residual disease capabilities Expands company’s presence across the cancer care continuum SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform and expanding the company’s ability to serve patients across the cancer … Continue reading Veracyte Completes Acquisition of C2i Genomics

Impact Newswire
Enhanc3D Genomics
Global, United States

Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships CAMBRIDGE, England–(BUSINESS WIRE)–Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Dr Daniel Turner as Chief Scientific Officer (CSO). Dan’s deep expertise in genomics technology development and commercialisation will be … Continue reading Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Impact Newswire
Vivodyne
Global, United States

Vivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology Officer

PHILADELPHIA–(BUSINESS WIRE)–Vivodyne, a biotech that accelerates the successful discovery, design, and development of human therapeutics, today announced the appointment of Elliot Menschik, M.D., Ph.D., to the company’s Board of Directors and to the executive role of Chief Technology Officer (CTO). Dr. Menschik brings more than 25 years of industry experience as a serial entrepreneur, startup investor, executive, Board director and educator. “We’re very excited to … Continue reading Vivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology Officer

Impact Newswire
Bruker
Global, United States

Bruker Announces Agreement to Acquire Chemspeed

Chemspeed Accelerates Bruker’s Laboratory Automation and Digitalization Drive BASEL, Switzerland–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced a definitive agreement for the acquisition of Chemspeed Technologies AG, aSwiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions. Chemspeed is focused on modular automation and robotics solutions for chemical research, pharma drug formulation, materials research for cleantech and consumer applications. “Our team is excited to join Bruker to further … Continue reading Bruker Announces Agreement to Acquire Chemspeed

Impact Newswire
Variational AI
Global

Variational AI Announces Generative AI Project With Merck

Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules VANCOUVER, British Columbia–(BUSINESS WIRE)–Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research Labs supported by the CQDM Quantum Leap program. “CQDM is pleased to have facilitated the establishment of collaborations for Variational AI by creating beneficial links … Continue reading Variational AI Announces Generative AI Project With Merck

Impact Newswire
Osivax
Europe, Global

Osivax Appoints Dr. Nicola Groth as Chief Medical Officer

LYON, France–(BUSINESS WIRE)–Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, announced today the appointment of Dr. Nicola Groth, MD, PhD to its executive committee as Chief Medical Officer. She brings over 25 years of experience in vaccine development with considerable expertise in influenza vaccines, from early-stage clinical development to approval and post-marketing commitments. Dr. Groth joins … Continue reading Osivax Appoints Dr. Nicola Groth as Chief Medical Officer

Impact Newswire
Depixus
Europe, Global

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

PARIS–(BUSINESS WIRE)–Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its first laboratory instrument, MAGNA One™, in 2024. “I’m thrilled to have … Continue reading Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

Impact Newswire